FDA unveiling faster method for approving gene-editing therapy
Vinay Prasad, who oversees gene therapies at the FDA, has said the plans will be published in early November., (NewsNation) — The U.S. Food and Drug Administration plans to unveil a quicker approach to approving custom gene-editing treatments. According to Bloomberg News, Vinay Prasad, who oversees gene therapies at theContinue Reading











